[Endocrine hypertension in primary aldosteronism and in Cushing's syndrome].
D000236:Adenoma / Q000150:complications; D000306:Adrenal Cortex Neoplasms / Q000378:metabolism; D000307:Adrenal Gland Diseases / Q000150:complications; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D003480:Cushing Syndrome / Q000150:complications*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D006929:Hyperaldosteronism / Q000150:complications* / Q000175:diagnosis; D006965:Hyperplasia; D006973:Hypertension / Q000209:etiology*; D007008:Hypokalemia / Q000150:complications; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology; D008722:Methods; D008875:Middle Aged; D012504:Saralasin / Q000494:pharmacology
D000324:Adrenocorticotropic Hormone; D012504:Saralasin; D006854:Hydrocortisone
Endokrine Hypertonie bei primärem Aldosteronismus und bei Cushing-Syndrom